國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

The role of microstructure in topica...

Langley, Nigel.

The role of microstructure in topical drug product development

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	The role of microstructure in topical drug product developmentedited by Nigel Langley, Bozena Michniak-Kohn, David W. Osborne.
其他作者:	Langley, Nigel.
出版者:	Cham :Springer International Publishing :2019.
面頁冊數:	xiv, 199 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Drug development.
電子資源:	https://doi.org/10.1007/978-3-030-17355-5
ISBN:	9783030173555$q(electronic bk.)

The role of microstructure in topical drug product development
The role of microstructure in topical drug product development[electronic resource] /edited by Nigel Langley, Bozena Michniak-Kohn, David W. Osborne. - Cham :Springer International Publishing :2019. - xiv, 199 p. :ill., digital ;24 cm. - AAPS advances in the pharmaceutical sciences series,v.362210-7371 ;. - AAPS advances in the pharmaceutical sciences series ;3..

Part I - Critical Quality Attributes: 1. Rheological Characterization in the Development of Topical Drug Products -- 2. In Vitro Release & Permeation Tests as Critical Quality Attributes in Topical Product Development -- 3. Determination of Particle Size and Microstructure in Topical Pharmaceuticals -- Part II - Role of API and Excipients: 4. Quality Assessment of API in Semisolid Topical Drug Products -- 5. The Role of Excipients in the Microstructure of Topical Semi-solid Drug Products.

Following the Semi-solid Microstructure Workshop sponsored by BASF and hosted by the Rutgers Center for Dermal Research, a pharmaceutical product development working group was formed. The group, known as the Q3 Working Group, selected the following five areas of focus: Particle/Globule Size and Distribution, Viscosity/Rheology/Spreadability, In Vitro Testing, State of API, State of Excipients. A committee was appointed for each of these five areas. The committees were tasked to review the literature, identify best practices, list experimental details required for an independent lab to duplicate the test, and propose scientific studies that may meaningfully advance this specific area of focus. Each committee has a chair (or co-chairs) that are the lead author(s) of the chapter. The Q3 Working Group members serve as the critical reviewers of each chapter, making suggestions that improve the quality of the document and that make each of the five chapters uniform in scope and content. Pharmaceutical development scientists that formulate topical products (creams, lotions, gels suspensions, foams, etc) and all the allied raw material suppliers, packaging suppliers, contract laboratories including CROs, CMOs and regulators need access to this book. Overall, the topic of semisolid microstructure is of equal importance to the generic pharmaceutical companies (filing Abbreviated New Drug Applications or ANDAs) and pharmaceutical companies filing New Drug Applications (NDAs) In addition to products applied to the skin, hair, and nails, The Role of Microstructure in Topical Drug Product Development crosses over and is essential reading to developers of oral suspensions, ophthalmic ointments and gels, otic suspension, vaginal semisolids and retention enemas.

ISBN: 9783030173555$q(electronic bk.)

Standard No.: 10.1007/978-3-030-17355-5doiSubjects--Topical Terms:

190608
Drug development.

LC Class. No.: RM301.25 / .R65 2019

Dewey Class. No.: 615.19

The role of microstructure in topical drug product development
LDR:03422nmm a2200349 a 4500 001 564928
003 DE-He213
005 20190807151448.0
006 m d
007 cr nn 008maaau
008 200327s2019 gw s 0 eng d
020 $a 9783030173555$q(electronic bk.)
020 $a 9783030173548$q(paper)
024 7 $a 10.1007/978-3-030-17355-5 $2 doi
033 8 6 $a nam a2200337 a 4500
035 $a 978-3-030-17355-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RM301.25 $b .R65 2019
072 7 $a TDCW $2 bicssc
072 7 $a MED072000 $2 bisacsh
072 7 $a TDC $2 thema
082 0 4 $a 615.19 $2 23
090 $a RM301.25 $b .R745 2019
245 0 4 $a The role of microstructure in topical drug product development $h [electronic resource] / $c edited by Nigel Langley, Bozena Michniak-Kohn, David W. Osborne.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a xiv, 199 p. : $b ill., digital ; $c 24 cm.
490 1 $a AAPS advances in the pharmaceutical sciences series, $x 2210-7371 ; $v v.36
505 0 $a Part I - Critical Quality Attributes: 1. Rheological Characterization in the Development of Topical Drug Products -- 2. In Vitro Release & Permeation Tests as Critical Quality Attributes in Topical Product Development -- 3. Determination of Particle Size and Microstructure in Topical Pharmaceuticals -- Part II - Role of API and Excipients: 4. Quality Assessment of API in Semisolid Topical Drug Products -- 5. The Role of Excipients in the Microstructure of Topical Semi-solid Drug Products.
520 $a Following the Semi-solid Microstructure Workshop sponsored by BASF and hosted by the Rutgers Center for Dermal Research, a pharmaceutical product development working group was formed. The group, known as the Q3 Working Group, selected the following five areas of focus: Particle/Globule Size and Distribution, Viscosity/Rheology/Spreadability, In Vitro Testing, State of API, State of Excipients. A committee was appointed for each of these five areas. The committees were tasked to review the literature, identify best practices, list experimental details required for an independent lab to duplicate the test, and propose scientific studies that may meaningfully advance this specific area of focus. Each committee has a chair (or co-chairs) that are the lead author(s) of the chapter. The Q3 Working Group members serve as the critical reviewers of each chapter, making suggestions that improve the quality of the document and that make each of the five chapters uniform in scope and content. Pharmaceutical development scientists that formulate topical products (creams, lotions, gels suspensions, foams, etc) and all the allied raw material suppliers, packaging suppliers, contract laboratories including CROs, CMOs and regulators need access to this book. Overall, the topic of semisolid microstructure is of equal importance to the generic pharmaceutical companies (filing Abbreviated New Drug Applications or ANDAs) and pharmaceutical companies filing New Drug Applications (NDAs) In addition to products applied to the skin, hair, and nails, The Role of Microstructure in Topical Drug Product Development crosses over and is essential reading to developers of oral suspensions, ophthalmic ointments and gels, otic suspension, vaginal semisolids and retention enemas.
650 0 $a Drug development. $3 190608
650 0 $a Drugs $x Design. $3 201742
650 1 4 $a Pharmaceutical Sciences/Technology. $3 338426
650 2 4 $a Pharmacy. $3 218145
700 1 $a Langley, Nigel. $3 850636
700 1 $a Michniak-Kohn, Bozena. $3 850637
700 1 $a Osborne, David W. $3 850638
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a AAPS advances in the pharmaceutical sciences series ; $v 3. $3 559046
856 4 0 $u https://doi.org/10.1007/978-3-030-17355-5
950 $a Biomedical and Life Sciences (Springer-11642)